Overview

Lung Cancer Surgery Market is predicted to value over USD 40 billion by 2027 end with a CAGR of over 6.5% during the forecast period 2020 to 2027.

Rising prevalence of lung cancer, increasing geriatric population, soaring healthcare expenditure across the world are some of the factors responsible for the lung cancer surgery market growth. Furthermore, there has been a rise in the number of chronic obstructive pulmonary disease, who then are at a high risk of getting diagnosed with lung cancer. These factors shall bolster the growth of the market.
The minimally invasive surgeries, robot-assisted surgeries and surgeries like cryo ablation radiofrequency ablation are some novel surgeries that are used for treating lung cancer. These novel processes provide different benefits like reduced hospital stay, less blood loss, smaller incision and shorter duration of chest tube. Therefore, these surgeries are preferred by both patients and surgeons. Furthermore, developing economies like Brazil and India have untapped potential for the lung cancer surgery market growth. With non-stringent regulations and lesser competition, the market in these countries is anticipated to proliferate during the forecast period. According to the World Bank estimates, the healthcare expenditure increased to over 5% of GDP in 2015. Such estimates shall boost the market growth.

Lung Cancer Surgery Market

Market Segmentation:

By Procedure
•   Thoracotomy
•   Lobectomy
•   Sleeve Resection
•   Segmentectomy
•   Pneumonectomy
•   Minimally Invasive Surgeries
By Devices

Surgical Instruments
Hand Instruments
Stapler
Forceps
Retractors
Rib Shear
Trocars
Cutters
Clamps
Scissors
Elevators
Other Hand Instruments
Monitoring and Visualizing Systems
Cameras and Video Support
Endoscopic Trocars with Optical View
Endosurgical Equipment

By Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

The market is fragmented into procedure, devices and region. The procedure segment is categorised into thoracotomy, lobectomy, sleeve resection, segmentectomy, pneumonectomy, minimally invasive surgeries. The devices segment is diversified into surgical instruments, hand instruments, monitoring and visualising systems and endosurgical equipment. The surgical instruments segment is anticipated to hold the largest lung cancer surgery market share owing to the soaring rise in the number of patients requiring lung cancer surgeries. The thoracotomy segment is anticipated to lead the market owing to its minimal invasion, reduced hospital stays and technological advancements.

Regional Analysis:

The North America region is predicted to lead the market during the forecast period owing to advancements in the healthcare infrastructure, a strong presence of key market players in the region, increasing geriatric population, favourable reimbursement scenarios for lung cancer are some factors contributing to the growth of the market.

Competitive Landscape:

Some of the key market players are Ethicon US LLC, Intutive Surgical Inc., Olympus Corporation, Accuray Inc., AngioDynamics Inc., Teleflex Inc., KARL STORZ GmbH, Ackermann Instrumente GmbH, Scanlan International Inc., Trokamed GmbH.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global lung cancer surgery market by devices, by procedures and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com